Summit Therapeutics (SUMM)

 

Latest News

Summit Therapeutics to Present at the Canaccord Genuity Growth Conference

Summit Therapeutics to Present at the Canaccord Genuity Growth Conference Summit Therapeutics plc ("Summit", or the "Company") SUMMIT THERAPEUTICS TO PRESENT AT THE CANACCORD GENUITY GROWTH CONFERENCE Oxford, UK, 3 August 2017 - Summit Therapeutics plc (NASDAQ: SMMT, AIM: SUMM), the drug discovery and developm...

Summit Therapeutics plc : Total voting rights

Summit Therapeutics plc: Total voting rights Summit Therapeutics plc ('Summit' or 'the Company') TOTAL VOTING RIGHTS Oxford, UK, 31 July 2017 - Summit Therapeutics plc (NASDAQ: SMMT, AIM: SUMM), make the following announcement that for the purposes of the Financial Conduct Authority's ("FCA") Disclosure and Transparency Rules, the issued ord...

Summit Therapeutics plc : Grant of Share Options and Restricted Stock Units

Summit Therapeutics plc: Grant of Share Options and Restricted Stock Units Summit Therapeutics plc ('Summit' or the 'Company') GRANT OF SHARE OPTIONS TO DIRECTORS, PDMRS AND EMPLOYEES AND GRANT OF RESTRICTED STOCK UNITS TO NON-EXECUTIVE DIRECTORS Oxford, UK, 19 July 2017 - Summit Therapeutics plc (AIM: SUMM, ...

Summit Therapeutics plc : Result of AGM

Summit Therapeutics plc: Result of AGM Summit Therapeutics plc ('Summit' or 'the Company') RESULT OF ANNUAL GENERAL MEETING Oxford, UK, 18 July 2017 - Summit Therapeutics plc (NASDAQ: SMMT, AIM: SUMM), the drug discovery and development company advancing therapies for Duchenne muscular dystrophy and Clostridium difficile infect...

All News

DateHeadlineSource
03-08-17Summit Therapeutics to Present at the Canaccord Genuity Growth ConferenceRNS
31-07-17Summit Therapeutics plc : Total voting rightsRNS
19-07-17Summit Therapeutics plc : Grant of Share Options and Restricted Stock UnitsRNS
18-07-17Summit Therapeutics plc : Result of AGMRNS
28-06-17Summit Therapeutics plc : Grant of Share OptionsRNS
28-06-17Summit Therapeutics plc : Exercise of Share OptionsRNS
22-06-17Summit Presents Data from Phase 1 Clinical Programme of Ezutromid at the EPNS CongressRNS
16-06-17Four AIM shares for a post-election worldInteractive Investor
15-06-17Summit Therapeutics to Participate in JMP Securities Life Sciences ConferenceRNS
14-06-17Summit losses fallStockMarketWire
14-06-17Summit Therapeutics plc : 1st Quarter ResultsRNS
13-06-17Summit confirms date of Q1 results announcementStockMarketWire
13-06-17Summit Therapeutics plc : Notice of ResultsRNS
05-06-17Summit highlights benefits of ridinilazole at ASM MicrobeStockMarketWire
05-06-17Summit Presents Positive New Preclinical Data on Novel CDI Antibiotic Ridinilazole at ASM Microbe 2017RNS
23-05-17Summit Announces Key Appointments to Strengthen Research & Development TeamRNS
15-05-17Summit completes PhaseOut DMD enrolmentStockMarketWire
15-05-17Summit Completes Enrolment of PhaseOut DMD, a Phase 2 Clinical Trial of Ezutromid in Patients with DMDRNS
02-05-17Summit Therapeutics plc: Phase 2 CoDIFy Trial Results Published in Lancet Infectious DiseasesRNS
25-04-17Summit Therapeutics plc : Notice of AGMRNS
12-04-17Summit Therapeutics plc : Grant of Share OptionsRNS
10-04-17Summit Therapeutics plc : Exercise of OptionsRNS
31-03-17Summit Therapeutics File US Annual Report on Form 20-FRNS
30-03-17Summit changes registered officeStockMarketWire
30-03-17Summit Therapeutics plc : Change of Registered OfficeRNS
30-03-17Summit Therapeutics to Present at the Needham Healthcare ConferenceRNS
29-03-17Summit Therapeutics Reports 4th Quarter and Year End Financial Results and Operational ProgressRNS
27-03-17Summit schedules FY resultsStockMarketWire
27-03-17Summit to extend PhaseOut DMD clinical trialStockMarketWire
27-03-17Summit Therapeutics plc : Notice of ResultsRNS
27-03-17Summit to Extend Ongoing PhaseOut DMD Clinical Trial of Ezutromid in Patients with DMDRNS
15-03-17Summit Therapeutics to Present at the Oppenheimer 27th Annual Healthcare ConferenceRNS
05-03-17Trends and Targets for 6/03/2017Trends and Targets
28-02-17Summit Therapeutics Recognises Tenth Annual Rare Disease DayRNS
23-02-17Summit Therapeutics plc : Exercise of WarrantsRNS
02-02-17Summit to take part in investor conferencesStockMarketWire
02-02-17Summit Therapeutics to Participate in February Investor ConferencesRNS
01-02-17Summit outlines Phase 3 programme for ridinilazoleStockMarketWire
01-02-17Summit Outline Phase 3 Programme for Novel CDI Antibiotic RidinilazoleRNS
25-01-17Summit Therapeutics plc : Holding(s) in CompanyRNS

RSS feeds

  • Editorial news feed for LSE:SUMM Editorial
  • Regulatory news feed for LSE:SUMM Regulatory